Bitopertin was awarded the Commissioner's National Priority Review Voucher (CNPV) and NDA is currently under FDA reviewUpdated data from the Phase 2 study of DISC-0974 in patients with myelofibrosis ...
VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, ...
As Vietnam accelerates its green transition and advances towards its national target of net zero emissions by 2050, sustainability is increasingly shaping how businesses operate, grow, and create long ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback